Generali Asset Management SPA SGR acquired a new position in shares of MetLife, Inc. (NYSE:MET – Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor acquired 5,692 shares of the financial services provider’s stock, valued at approximately $466,000.
Other large investors have also bought and sold shares of the company. CX Institutional lifted its holdings in shares of MetLife by 15.9% in the fourth quarter. CX Institutional now owns 68,005 shares of the financial services provider’s stock worth $5,568,000 after acquiring an additional 9,337 shares during the last quarter. Bank of New York Mellon Corp lifted its stake in MetLife by 109.2% in the 4th quarter. Bank of New York Mellon Corp now owns 8,826,658 shares of the financial services provider’s stock valued at $722,727,000 after purchasing an additional 4,606,748 shares during the last quarter. Smartleaf Asset Management LLC boosted its position in MetLife by 27.3% in the fourth quarter. Smartleaf Asset Management LLC now owns 13,692 shares of the financial services provider’s stock valued at $1,116,000 after buying an additional 2,940 shares in the last quarter. Zurcher Kantonalbank Zurich Cantonalbank increased its holdings in shares of MetLife by 1.7% during the fourth quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 776,244 shares of the financial services provider’s stock worth $63,559,000 after buying an additional 12,723 shares in the last quarter. Finally, B. Metzler seel. Sohn & Co. Holding AG bought a new position in shares of MetLife in the 3rd quarter valued at $2,960,000. 94.99% of the stock is owned by institutional investors and hedge funds.
Analysts Set New Price Targets
A number of equities research analysts recently weighed in on the company. Keefe, Bruyette & Woods reduced their price objective on MetLife from $100.00 to $98.00 and set an “outperform” rating on the stock in a research report on Wednesday, February 12th. Wells Fargo & Company upped their price objective on MetLife from $92.00 to $97.00 and gave the company an “overweight” rating in a research note on Wednesday, February 19th. TD Cowen boosted their target price on shares of MetLife from $97.00 to $99.00 and gave the stock a “buy” rating in a report on Wednesday, November 27th. StockNews.com downgraded shares of MetLife from a “buy” rating to a “hold” rating in a research note on Thursday, January 9th. Finally, JPMorgan Chase & Co. boosted their price objective on shares of MetLife from $86.00 to $88.00 and gave the stock an “overweight” rating in a research note on Tuesday, January 7th. Two analysts have rated the stock with a hold rating and twelve have given a buy rating to the stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $94.58.
MetLife Stock Performance
MET stock opened at $82.68 on Friday. MetLife, Inc. has a 1-year low of $67.30 and a 1-year high of $89.05. The company has a current ratio of 0.16, a quick ratio of 0.16 and a debt-to-equity ratio of 0.54. The stock has a 50-day moving average price of $83.44 and a 200-day moving average price of $82.57. The firm has a market cap of $56.33 billion, a PE ratio of 13.85, a price-to-earnings-growth ratio of 0.65 and a beta of 1.04.
MetLife (NYSE:MET – Get Free Report) last issued its quarterly earnings results on Wednesday, February 5th. The financial services provider reported $2.08 earnings per share (EPS) for the quarter, missing the consensus estimate of $2.13 by ($0.05). MetLife had a net margin of 6.19% and a return on equity of 20.42%. As a group, equities research analysts expect that MetLife, Inc. will post 9.65 earnings per share for the current year.
MetLife Announces Dividend
The business also recently declared a quarterly dividend, which was paid on Tuesday, March 11th. Shareholders of record on Tuesday, February 4th were issued a $0.545 dividend. This represents a $2.18 dividend on an annualized basis and a yield of 2.64%. The ex-dividend date was Tuesday, February 4th. MetLife’s payout ratio is 36.52%.
About MetLife
MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.
Featured Stories
- Five stocks we like better than MetLife
- What is the NASDAQ Stock Exchange?
- Everything About Amazon Stock Signals a Buy—Time to Load Up?
- How Can Investors Benefit From After-Hours Trading
- 5 Reasons Five Below’s Stock Price Is Heading Higher This Year
- Why Invest in High-Yield Dividend Stocks?
- Broadcom: Why the Chip Stock Remains a Top Long-Term AI Play
Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MetLife, Inc. (NYSE:MET – Free Report).
Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.